Endocrine System Diseases: Clinical Trials

43 trials for Endocrine System Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

43 active not recruiting. 43 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 443Active not recruiting 43

Follow Endocrine System Diseases: new trials by email Literature Review of Endocrine System Diseases trials Research Report on Endocrine System Diseases

Trials (filtered) newest first · largest first

All 43 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity
Tirzepatide - Diabetes Mellitus, Type 2, Obesity
Phase 4Active not recruitingEli Lilly and Company3442026-02-272026-08-21
Total Intravenous and Balanced Anesthesia in Diabetic Patients Undergoing Video-Assisted Thoracoscopy
Propofol + fentanyl + Atracurium, Isoflurane and Atracurium - Diabete Mellitus, VATS
Phase 4Active not recruitingAin Shams University602025-12-012026-03-27
Continuous Glucose Monitoring By DExcom iN PEople Followed for Type 2 DIabeTes on Insulin Therapy in the Kingdom of Saudi Arabia
Real-Time Continuous Glucose Monitoring - Type 2 Diabetes on Insulin
Phase 4Active not recruitingDexCom, Inc.2002025-11-242026-05-22
Comparison of Two Timings of Levothyroxine Intake in Hypothyroid Patients: A Cross-over Randomized Control Trial
Levothyroxine Pill - Hypothyroidism Primary
Phase 4Active not recruitingElyes Kamoun1022025-07-242026-10-28
Effects of iGlarLixi Versus iGlar on Liver Fat Content in Patients With Type 2 Diabetes Mellitus Combined With Metabolic Dysfunction-associated Steatotic Liver Disease
iGlarLixi, IGlar U100 - Metabolic Dysfunction-Associated Steatotic Liver Disease, Diabetes Mellitus Type 2
Phase 4Active not recruitingThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School362025-03-292026-06-22
Effects of D-Chiro-Inositol Combined with Metformin on Insulin Resistance in People with Overweight or Obesity and T2DM
D-Chiro-Inositol Combined with Metformin, Placebo in combination with metformin - Type 2 Diabetes, Overweight and Obese Adults
Phase 4Active not recruitingCampus Bio-Medico University162025-01-102025-03-11
Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists
SGLT-2 inhibitor, GLP1-RA - Type 2 Diabetes (T2DM)
Phase 4Active not recruitingMaryAnn Banerji602024-12-212026-01-08
Effect of Chromium on Blood Sugar After Sacroiliac Joint Injection
Chromium - Sacro Iliac Joint Pain, Diabetes
Phase 4Active not recruitingFayoum University602024-06-032024-11-29
DIALYSIS-TIR Study
Semaglutide, Placebo - Type 2 Diabetes, End Stage Renal Disease on Dialysis
Phase 4Active not recruitingUniversity of Texas Southwestern Medical Center432023-12-052026-01-13
Diabetes Diagnosis, Management, Prevention and Education in Guinea-Bissau
BCG vaccine (two doses, 4 weeks apart), Saline placebo (Two doses, 4 weeks apart) - Diabetes Mellitus, BCG Vaccination Reaction
Phase 4Active not recruitingBandim Health Project2002023-12-012026-02-17
Effect of Metformin, a Drug Used to Treat Diabetes, vs Placebo
Metformin Extended Release (ER) Oral Tablet, Placebo - NIDDM, Obesity
Phase 4Active not recruitingUniversity of California, Los Angeles1502023-11-222026-06-08
Effects of Berberine on Preventing Cardiovascular Disease and Diabetes Mellitus
Berberine plus lifestyle intervention, Placebo plus lifestyle intervention - PreDiabetes, Abdominal Obesity
Phase 4Active not recruitingChina National Center for Cardiovascular Diseases20242023-10-312025-12-31
First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive Patients
Olaparib, Bevacizumab - Carcinoma, Ovarian Epithelial
Phase 4Active not recruitingMario Negri Institute for Pharmacological Research1902023-09-152026-06-25
Glucagon Suppression by Hyperglycemia in the Presence and Absence of Amino Acid Infusion
Dextrose, Clinisol 15% - Healthy, Type 2 Diabetes
Phase 4Active not recruitingMayo Clinic302023-05-302026-02-13
Metabolic Responses of Metformin and Genetic Polymorphisms of SLC22A1 Gene in PCOS
Metformin Hydrochloride - Polycystic Ovary Syndrome, Metformin
Phase 4Active not recruitingBangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh1502023-05-272026-10-07
Treating Leg Symptoms in Women With X-linked Adrenoleukodystrophy
Pramipexole, Placebo - Adrenoleukodystrophy, Restless Legs Syndrome
Phase 4Active not recruitingMassachusetts General Hospital242023-04-012026-07-01
A Study of Cardiovascular Events iN Diabetes Plus
Semaglutide Oral Tablet, Placebo oral tablet - Diabetes Mellitus, Type 2
Phase 4Active not recruitingUniversity of Oxford212962023-03-132026-06-23
Microbiological Effect of 0.12% Chlorhexidine Digluconate and 0.05% Cetylpyridinium Chloride vs Probiotics (Lactobacillus Reuteri Prodentis) on Porphyromonas Gingivalis.
Mouthwash with chlorhexidine and cetylpyridine chloride, Probiotic (Lactobacillus reuteri Prodentis - Periodontal Diseases, Diabetes Mellitus Type 2
Phase 4Active not recruitingUniversidad de Colima202023-01-082026-03-24
Semaglutide vs Sitagliptin
Semaglutide Treatment, Sitagliptin 100mg - Liver Transplant; Complications, Diabetes Mellitus
Phase 4Active not recruitingUniversity Health Network, Toronto582022-10-262026-10-14
Diabetes in African Youth
Libre 2, Device for SMBG and Libre Pro - type1diabetes
Phase 4Active not recruitingUniversity of Minnesota1882022-08-152026-11-05

Showing 20 of 43. Sign in to see all of them.

Narrower conditions

Diabetes Mellitus, Type 2 (15)  ·  Diabetes Mellitus (13)  ·  Obesity (4)  ·  Cardiovascular Diseases (3)  ·  Diabetes Mellitus, Type 1 (3)  ·  Insulin Resistance (2)  ·  Overweight (2)  ·  Pancreatic Neoplasms (2)  ·  Polycystic Ovary Syndrome (2)  ·  Prediabetic State (2)  ·  Adrenoleukodystrophy (1)  ·  Angina Pectoris (1)  ·  Atherosclerosis (1)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Medullary (1)

Broader conditions

Metabolic Diseases (32)  ·  Nutritional and Metabolic Diseases (32)  ·  Glucose Metabolism Disorders (30)  ·  Diabetes Mellitus (19)  ·  Pathological Conditions, Signs and Symptoms (12)  ·  Female Urogenital Diseases and Pregnancy Complications (8)  ·  Neoplasms (8)  ·  Nutrition Disorders (8)  ·  Signs and Symptoms (8)  ·  Urogenital Diseases (8)  ·  Body Weight (7)  ·  Female Urogenital Diseases (7)  ·  Overnutrition (7)  ·  Neoplasms by Site (6)

Interventions

Metformin (3)  ·  semaglutide (3)  ·  Aspirin (2)  ·  Sitagliptin Phosphate (2)  ·  Tirzepatide (2)  ·  Amino Acids (1)  ·  Analgesia (1)  ·  Anesthesia, Epidural (1)  ·  Atorvastatin (1)  ·  Atracurium (1)  ·  BCG Vaccine (1)  ·  Bariatric Surgery (1)  ·  Berberine (1)  ·  Bevacizumab (1)  ·  Calcium (1)

Sponsors

Eli Lilly and Company (2)  ·  University of Oxford (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Ain Shams University (1)  ·  Alimera Sciences (1)  ·  Bandim Health Project (1)  ·  Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1)  ·  Campus Bio-Medico University (1)  ·  Children's Hospital Medical Center, Cincinnati (1)  ·  China National Center for Cardiovascular Diseases (1)  ·  DexCom, Inc. (1)  ·  Elyes Kamoun (1)  ·  European Institute of Oncology (1)  ·  Exelixis (1)  ·  Fayoum University (1)

Countries

United States (17)  ·  Italy (5)  ·  Canada (4)  ·  China (3)  ·  Israel (3)  ·  Netherlands (3)  ·  United Kingdom (3)  ·  Australia (2)  ·  Egypt (2)  ·  Mexico (2)  ·  Romania (2)  ·  Spain (2)  ·  Taiwan (2)  ·  Argentina (1)  ·  Bangladesh (1)

Top investigators

Adrian Vella, MD (1)  ·  Amy S Shah, MD MS (1)  ·  Antoinette Moran (1)  ·  Atef M Sayed, MD (1)  ·  David J Leehey (1)  ·  David Preiss (1)  ·  Dong-Xin Wang, MD, PhD (1)  ·  Eugenia Carvalho, PhD (1)  ·  Federica Tomao (1)  ·  Florian S Eichler, MD (1)  ·  Haibo Zhang, MD (1)  ·  I-Te Lee (1)  ·  Ildiko Lingvay, MD, MPH, MSCS (1)

Results publications

PMID 20660041, PMID 24533710, PMID 29653635, PMID 30146931, PMID 30146932, PMID 30959948, PMID 31986094, PMID 32022887, PMID 34389568, PMID 34400461, PMID 35393614, PMID 35403447, PMID 36413436, PMID 36871000, PMID 37012015, PMID 37230523, PMID 37916745, PMID 38052385, PMID 38237868, PMID 38385506, PMID 39501183, PMID 39548016, PMID 40010818, PMID 40760017, PMID 40935429, PMID 41887289, PMID 42184419, PMID 42216096, PMID 42670961, PMID 42911768

NIH funding

2008 (1), K23DK117041 (1), R01DK116231 (1)